This is a preview of subscription content, log in via an institution to check access.
Reference
Jang C, et al. Combinatorial therapy is a safe and durable treatment option in ALK-rearranged non-small cell lung cancer with an acquired MET exon 14 skipping mutation mediated resistance to alectinib: a case report. Translational Lung Cancer Research 12: 2558-2564, No. 12, Dec 2023. Available from: URL: https://dx.doi.org/10.21037/tlcr-23-613
Rights and permissions
About this article
Cite this article
Alectinib. Reactions Weekly 1995, 16 (2024). https://doi.org/10.1007/s40278-024-53279-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-53279-6